SenoRx Completes Sale to C. R. Bard
06 juil. 2010 09h15 HE
|
SenoRx, Inc.
IRVINE, Calif., July 6, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that the acquisition of the company by C. R. Bard, Inc. (NYSE:BCR) was completed today. Under the terms of...
SenoRx Reports Continuing Revenue Growth and Strong Gross Margin in First Quarter 2010 on Strengthening International Market
05 mai 2010 17h35 HE
|
SenoRx, Inc.
IRVINE, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its first quarter ended March 31, 2010. Revenue for the quarter increased 4.3 percent to...
SenoRx to be Acquired by C. R. Bard for Approximately $213 Million
05 mai 2010 09h15 HE
|
SenoRx, Inc.
IRVINE, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced it has entered into a definitive merger agreement with C. R. Bard (NYSE:BCR) at a price of $11 per share, or...
SenoRx Announces First Quarter 2010 Conference Call and Webcast
08 avr. 2010 10h00 HE
|
SenoRx, Inc.
IRVINE, Calif., April 8, 2010 (GLOBE NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will host its investor conference call to review its First Quarter 2010 financial results on Thursday,...
SenoRx Board Appoints John T. Buhler as Chief Executive Officer and Member of Board of Directors
16 mars 2010 13h50 HE
|
SenoRx, Inc.
IRVINE, Calif., March 16, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) announced today that its Board of Directors appointed acting Chief Executive Officer John T. Buhler as the company's new...
SenoRx Mourns Death of CEO Lloyd Malchow
15 mars 2010 16h41 HE
|
SenoRx, Inc.
IRVINE, Calif., March 15, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today with great sadness announced the death of its Chairman and Chief Executive Officer, Lloyd H. Malchow. Mr. Malchow...
SenoRx Reports Record Revenues and Strong Gross Margin for Fourth Quarter and Fiscal Year 2009 With Continuing Positive Cash Flow
24 févr. 2010 16h10 HE
|
SenoRx, Inc.
IRVINE, Calif., Feb. 24, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its fourth quarter and fiscal year 2009. For the quarter ended December 31, 2009,...
SenoRx Announces CEO to Take Medical Leave of Absence
08 févr. 2010 08h00 HE
|
SenoRx, Inc.
IRVINE, Calif., Feb. 8, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Chairman and Chief Executive Officer Lloyd H. Malchow is taking an indefinite medical leave of absence...
SenoRx Announces Fourth Quarter and Fiscal Year 2009 Conference Call and Webcast
25 janv. 2010 10h00 HE
|
SenoRx, Inc.
IRVINE, Calif., Jan. 25, 2010 (GLOBE NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will host its investor conference call to review its Q4/FY2009 financial results and guidance for 2010 on...
SenoRx Found Not Liable for Patent Infringement
18 déc. 2009 08h00 HE
|
SenoRx, Inc.
IRVINE, Calif., Dec. 18, 2009 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that a jury delivered a verdict in favor of SenoRx in a lawsuit brought by Hologic, Inc., Cytyc Corp., and...